Related Experiment Videos
Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: a large randomized,
J Donnez1, G Vilos, M J Gannon
1Service de Gynecologie, University St. Luc, Brussels, Belgium.
Fertility and Sterility
|July 1, 1997
Summary
Pre-treating with goserelin before endometrial ablation significantly improves amenorrhea rates and simplifies surgery for dysfunctional uterine bleeding. This combination therapy offers superior outcomes compared to ablation alone.
Area of Science:
- Reproductive Medicine
- Gynecologic Surgery
- Pharmacological Interventions
Background:
- Dysfunctional uterine bleeding (DUB) is a common gynecological condition.
- Endometrial ablation is a surgical treatment option for DUB.
- The efficacy of pre-operative hormonal therapy requires further investigation.
Purpose of the Study:
- To evaluate the effectiveness of goserelin as a pre-treatment for endometrial ablation in managing DUB.
- To compare outcomes between patients receiving goserelin and placebo before surgery.
Main Methods:
- A multicenter, prospective, randomized, double-blind study was conducted.
- Premenopausal women with DUB received either goserelin or a placebo monthly for two months prior to endometrial ablation.
- Outcomes included amenorrhea rates, endometrial histology, pain, blood loss, and surgical parameters.
Main Results:
- Goserelin treatment resulted in significantly higher amenorrhea rates (40% vs. 26%) at 24 weeks post-surgery.
- Endometrial thickness was reduced, and gland atrophy was more pronounced in the goserelin group.
- Surgery was shorter (22% reduction) and easier, with lower fluid absorption in the goserelin group.
Conclusions:
- Goserelin in combination with endometrial ablation is superior to ablation alone for DUB treatment.
- Pre-operative goserelin improves surgical outcomes and amenorrhea rates.
- The combined approach offers a safe and effective treatment for DUB.